Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.
Press releases published on July 7, 2025
Lifestyle Expert Meaghan Murphy Shares Her Favorite Wellness Tech for Summer Recovery with YourUpdateTV
GlobeNewswire
·
July 7, 2025
NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- With wellness and recovery more top of mind than ever, lifestyle expert and author Meaghan Murphy has teamed up with RENPHO and D S Simon Media for a special Prime Day segment featuring tech-forward self-care …
Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option
GlobeNewswire
·
July 7, 2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the release of its Q-FIX KNOTLESS All-Suture Anchor for soft tissue-to-bone fixation indications across multiple joint spaces including Shoulder, Hip, and Foot …
The American Society of Pain and Neuroscience (ASPN) Publishes Consensus Guidelines for the Use of 60-Day Peripheral Nerve Stimulation (PNS) Therapy, Highlighting Strong Clinical Applications for SPR® SPRINT® PNS
GlobeNewswire
·
July 7, 2025
CLEVELAND, July 07, 2025 (GLOBE NEWSWIRE) -- Recently, ASPN published the first clinical guidelines focused specifically on the use of 60-day PNS (SPRINT PNS), offering evidence-based best practice recommendations. It includes positive recommendations for …
Joybird’s Treehouse to Host Free Webinar on Academic Success for Underserved Students
GlobeNewswire
·
July 7, 2025
Dallas, TX , July 07, 2025 (GLOBE NEWSWIRE) -- Joybird’s Treehouse, a culturally responsive education platform founded by veteran educator Joyce Caraway, today announced its second national webinar, “Master the Grade: Keys to Academic Success …
Corza Medical Announces the Launch of the Expanded Onatec Ophthalmic Suture Portfolio
GlobeNewswire
·
July 7, 2025
PARSIPPANY, New Jersey, July 07, 2025 (GLOBE NEWSWIRE) -- Corza Medical, a leading global medical technology company, today announced the launch of its expanded Onatec Ophthalmic Suture Portfolio. This marks a significant extension of the product range, …
Skin Care and Laser Physicians of Beverly Hills Welcomes Double Board-Certified Dermatologist
GlobeNewswire
·
July 7, 2025
LOS ANGELES, July 07, 2025 (GLOBE NEWSWIRE) -- Skin Care and Laser Physicians of Beverly Hills are proud to introduce the newest addition to their esteemed dermatology practice in Los Angeles. Dr. Cory Kosche, a Mohs and Cosmetic Fellowship-Trained …
Immix Biopharma Announces Accelerated NEXICART-2 Clinical Trial Progress in relapsed/refractory AL Amyloidosis
GlobeNewswire
·
July 7, 2025
– National Footprint of NEXICART-2 Trial Sites Expanded – – On track for first Biologics License Application (BLA) approved cell therapy in unaddressed orphan indication – – NEXICART-2 interim results were presented at ASCO 2025 – LOS ANGELES, CA, July …
Nudj Health Appoints Dr. Padmaja Patel as Chief Medical Officer to Advance Lifestyle Medicine Services
GlobeNewswire
·
July 7, 2025
PASADENA, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Nudj Health, the leading AI-powered lifestyle medicine services company, is proud to announce the appointment of Dr. Padmaja Patel as Chief Medical Officer of Lifestyle Medicine Services. In this role, Dr …
Synfini Adds $8.9 Million Discovery Funding to Speed Small Molecule Drug Development
GlobeNewswire
·
July 7, 2025
MENLO PARK, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Synfini, Inc., a trailblazer in AI-driven chemistry automation, today announced a $8.9 million expansion of its round, led by JSL Health Capital and supported by a strong syndicate of early-stage …
SELLAS Life Sciences Appoints Linghua Wang, MD, PhD, to Scientific Advisory Board
GlobeNewswire
·
July 7, 2025
NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma
GlobeNewswire
·
July 7, 2025
In an ongoing Phase 1 trial published in Nature Medicine, MB-101 was well-tolerated and 50% of patients achieved stable disease or better with two partial responses and two complete responses lasting 7.5 and 66+ months, respectively Preclinical data …
Ophthalmology Drugs Market to Reach $26.28 Billion by 2030—Vision Care Becomes a Strategic Growth Pillar | MarketsandMarkets™.
GlobeNewswire
·
July 7, 2025
Delray Beach, FL, July 07, 2025 (GLOBE NEWSWIRE) -- What’s powering a $26.28 billion opportunity? The global ophthalmology drugs market, valued at US$18.34 billion in 2024 stood at US$19.52 billion in 2025 and is projected to advance at a resilient CAGR of …
Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment
GlobeNewswire
·
July 7, 2025
THE WOODLANDS, TX, July 07, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the next CEO Corner segment has …
Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries
GlobeNewswire
·
July 7, 2025
Includes Conduit’s first composition of matter patent filing for AZD5658 and multiple new combination filings for AZD1656 and AZD5658 Patents derived from AI-led analysis conducted in partnership with Sarborg Limited NAPLES, Fla. and CAMBRIDGE, United …
Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025
GlobeNewswire
·
July 7, 2025
Planned submission of IND application in 2025; Phase 1 clinical trial to follow if IND application approved No new PTSD drug approvals in the U.S. in nearly 25 years; large potential addressable market for SPC-15 worldwide SARASOTA, FL, July 07, 2025 ( …
Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer
GlobeNewswire
·
July 7, 2025
TARPON SPRINGS, Fla., July 7, 2025 -- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway inhibitor—as …
Inspire Medical Systems, Inc. to Report Second Quarter 2025 Financial Results on August 4, 2025
GlobeNewswire
·
July 7, 2025
MINNEAPOLIS, July 07, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2025 after the close of trading on Monday, August 4. Inspire’s management team will host a …
Collegium Announces $150 Million Share Repurchase Program
GlobeNewswire
·
July 7, 2025
STOUGHTON, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced its Board …
JenaValve's Trilogy™ THV System Procedures Live Broadcast at New York Valves 2025
GlobeNewswire
·
July 7, 2025
IRVINE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the New York Valves 2025 conference, with two live case …
Novel Digital Test Provides Revolutionary Tool to Assess Brain Chemistry
GlobeNewswire
·
July 7, 2025
SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- For the first time, a study shows a digital assessment can provide a scientific measure of acetylcholine – a key brain chemical whose decline signals the progression of cognitive impairment and Alzheimer’s …